OpAns LLC

OpAns LLC is a well-established contract research organization specializing in mass spectrometry, separations chemistry, pediatric clinical trial support, and micro-sampling techniques, including the use of their patented amasse(TM) dried bio-fluid specimen collection device. With a focus on research, development, and personalized testing, they cater to various industries such as government (EPA, NIH, NCATS), chemical industries, hospitals, clinics, and the court system. Their expertise in areas like in vitro screening, development studies, and personalized testing has positioned them as an industry leader. Founded in 2004, OpAns LLC serves the biotechnology and healthcare industries. OpAns LLC has a strong track record of providing optimized analytical solutions to healthcare and R&D organizations since its inception. They have successfully supported a range of clients and leveraged the insights from each area of support to fuel the development of other areas. Their research studies encompass in vitro screening, bioanalytical work, while development studies include non-clinical and clinical aspects, as well as environmental considerations. Furthermore, their personalized testing services cater to hospitals, clinics, and courts, offering diagnostic and monitoring solutions. Despite not having specific details about the headquarters or recent investments, OpAns LLC’s extensive experience, diversified client portfolio, and focus on cutting-edge analytical solutions position them as a compelling prospect for potential investors in the biotechnology and healthcare sectors.